Raffa Wealth Management’s Halozyme HALO Stock Holding History

Raffa Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$157	Buy	2 +1	+100%	+$68	﹤0.01%	1299
2026 Q1	$65	Buy	+1	New	+$70	﹤0.01%	1363
2022 Q4	–	Sell	-33	Closed	-$1.3K	–	1105
2022 Q3	$1.3K	Hold	33	–	–	﹤0.01%	718
2022 Q2	$1.45K	Hold	33	–	–	﹤0.01%	693
2022 Q1	$1.32K	Hold	33	–	–	﹤0.01%	761
2021 Q4	$1.33K	Hold	33	–	–	﹤0.01%	778
2021 Q3	$1.34K	Hold	33	–	–	﹤0.01%	727
2021 Q2	$1.5K	Hold	33	–	–	﹤0.01%	705
2021 Q1	$1.38K	Hold	33	–	–	﹤0.01%	740
2020 Q4	$1.41K	Hold	33	–	–	﹤0.01%	646
2020 Q3	$867	Buy	33 +11	+50%	+$306	﹤0.01%	711
2020 Q2	$590	Buy	22 +8	+57%	+$180	﹤0.01%	784
2020 Q1	$252	Buy	+14	New	+$266	﹤0.01%	824

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Raffa Wealth Management's HALO Position: Q2 2026 in Review

Raffa Wealth Management increased its Halozyme (HALO) stake by 100% in Q2 2026, buying an estimated $68 and bringing the position to 2 shares worth $157. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

Raffa Wealth Management first reported a position in HALO in Q1 2020 and has held it in 13 quarters since. The position peaked at $1.5K in Q2 2021. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Raffa Wealth Management held 2 shares of Halozyme worth $157 as of Q2 2026.
Raffa Wealth Management bought 1 Halozyme share in Q2 2026, an estimated $68.
Halozyme made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1299 holding.
Raffa Wealth Management first reported a position in Halozyme in Q1 2020 and has held it in 13 quarters since.
Raffa Wealth Management's Halozyme position peaked at $1.5K in Q2 2021.
629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.